↓ Skip to main content

Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease

Overview of attention for article published in Psychopharmacology, October 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter
1 X user
patent
1 patent
wikipedia
2 Wikipedia pages

Readers on

mendeley
107 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease
Published in
Psychopharmacology, October 2008
DOI 10.1007/s00213-008-1351-0
Pubmed ID
Authors

Evelin L. Schaeffer, Orestes V. Forlenza, Wagner F. Gattaz

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Indonesia 1 <1%
France 1 <1%
Canada 1 <1%
Unknown 104 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 15%
Student > Ph. D. Student 15 14%
Student > Bachelor 11 10%
Student > Master 9 8%
Other 7 7%
Other 23 21%
Unknown 26 24%
Readers by discipline Count As %
Agricultural and Biological Sciences 18 17%
Neuroscience 15 14%
Psychology 15 14%
Medicine and Dentistry 13 12%
Nursing and Health Professions 4 4%
Other 13 12%
Unknown 29 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2019.
All research outputs
#4,509,531
of 22,772,779 outputs
Outputs from Psychopharmacology
#1,174
of 5,342 outputs
Outputs of similar age
#16,610
of 90,518 outputs
Outputs of similar age from Psychopharmacology
#11
of 40 outputs
Altmetric has tracked 22,772,779 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,342 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 90,518 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.